Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Eilertsen, Marte ^a   Andersen, Sigve ^a,b   Al Saad, Samer ^a,b   Kiselev, Yury ^a   Donnem, Tom ^a,b   Stenvold, Helge ^a,b   Pettersen, Ingvild ^a   Al Shibli, Khalid ^a,c   Richardsen, Elin ^a,b   Busund, Lill Tove ^a,b   Bremnes, Roy M ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c NORDLAND HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 2; MONOCARBOXYLATE TRANSPORTER 3; MONOCARBOXYLATE TRANSPORTER 4; TUMOR MARKER; COTRANSPORTER; MONOCARBOXYLATE TRANSPORT PROTEIN 1; MONOCARBOXYLATE TRANSPORTER; MUSCLE PROTEIN; SLC16A3 PROTEIN, HUMAN; SLC16A4 PROTEIN, HUMAN; SLC16A7 PROTEIN, HUMAN;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; TISSUE MICROARRAY; UPREGULATION; CARCINOMA, NON-SMALL-CELL LUNG; GENETICS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE PROTEINS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; STROMAL CELLS; SYMPORTERS; TUMOR MARKERS, BIOLOGICAL;

EID: 84907227069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105038     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA: a cancer journal for clinicians 61: 69-90.
2. Wilson WR, Hay MP (2011) Targeting hypoxia in cancer therapy. Nature reviews Cancer 11: 393-410.
3. Andersen S, Donnem T, Al-Saad S, Al-Shibli K, Stenvold H, et al. (2011) Correlation and coexpression of HIFs and NOTCH markers in NSCLC. Anticancer research 31: 1603-1606.
4. Andersen S, Donnem T, Stenvold H, Al-Saad S, Al-Shibli K, et al. (2011) Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival. PloS one 6: e23847.
5. Andersen S, Eilertsen M, Donnem T, Al-Shibli K, Al-Saad S, et al. (2011) Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Lung Cancer 72: 294-302.
6. Eilertsen M, Pettersen I, Andersen S, Martinez I, Donnem T, et al. (2012) In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histology. Anticancer research 32: 4729-4736.
7. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nature reviews Cancer 11: 85-95.
8. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nature reviews Cancer 4: 891-899.
9. Pinheiro C, Longatto-Filho A, Azevedo-Silva J, Casal M, Schmitt FC, et al. (2012) Role of monocarboxylate transporters in human cancers: state of the art. Journal of bioenergetics and biomembranes 44: 127-139.
10. Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. The Biochemical journal 343 Pt 2: 281-299.
11. Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer research 66: 632-637.
12. Koukourakis MI, Giatromanolaki A, Bougioukas G, Sivridis E (2007) Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer biology & therapy 6: 1476-1479.
13. Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer cell 13: 472-482.
14. Detterbeck FC, Boffa DJ, Tanoue LT (2009) The new lung cancer staging system. Chest 136: 260-271.
15. Donnem T, Al-Saad S, Al-Shibli K, Delghandi MP, Persson M, et al. (2007) Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 13: 6649-6657.
16. Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, et al. (2006) The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Molecular pharmacology 70: 2108-2115.
17. Boidot R, Vegran F, Meulle A, Le Breton A, Dessy C, et al. (2012) Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer research 72: 939-948.
18. Chen H, Wang L, Beretov J, Hao J, Xiao W, et al. (2010) Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression. Clinical & experimental metastasis 27: 557-569.
19. de Oliveira AT, Pinheiro C, Longatto-Filho A, Brito MJ, Martinho O, et al. (2012) Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). Journal of bioenergetics and biomembranes 44: 171-178.
20. Chen JL, Lucas JE, Schroeder T, Mori S, Wu J, et al. (2008) The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS genetics 4: e1000293.
21. Izumi H, Takahashi M, Uramoto H, Nakayama Y, Oyama T, et al. (2011) Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer science 102: 1007-1013.
22. Sonveaux P, Copetti T, De Saedeleer CJ, Vegran F, Verrax J, et al. (2012) Targeting the lactate transporter MCT1 in endothelial cells inhibits lactateinduced HIF-1 activation and tumor angiogenesis. PloS one 7: e33418.
23. Vegran F, Boidot R, Michiels C, Sonveaux P, Feron O (2011) Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis. Cancer research 71: 2550-2560.
24. Rattigan YI, Patel BB, Ackerstaff E, Sukenick G, Koutcher JA, et al. (2012) Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Experimental cell research 318: 326-335.
25. Meijer TW, Schuurbiers OC, Kaanders JH, Looijen-Salamon MG, de Geus-Oei LF, et al. (2012) Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4. Lung Cancer 76: 316-323.
26. Busk M, Walenta S, Mueller-Klieser W, Steiniche T, Jakobsen S, et al. (2011) Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 99: 404-411.